Internal use only. This site is under development and not yet ready for wide distribution. Content may change.

Adults

VEXAS syndrome

Semi-urgentWithin 4–8 weeks

A man over 50 with recurrent inflammation (fever, chondritis, rash), macrocytic anemia or other cytopenias, and thrombosis.

What to look for

  • Usually men over 50 (about 1 in 4,000 men over 50). Women, especially with X-chromosome loss, are occasionally affected.
  • Recurrent fevers, ear or nose chondritis, neutrophilic dermatosis (Sweet-like), vasculitis, lung infiltrates
  • Macrocytic anemia, thrombocytopenia, or myelodysplasia
  • Venous thromboembolism
  • Often labeled relapsing polychondritis, Sweet syndrome, or MDS that doesn't fully fit

What to do

  • Send CBC with smear (macrocytosis), CRP/ESR and a metabolic panel.
  • Diagnosis is by UBA1 somatic mutation testing. Bone marrow often shows vacuoles in myeloid and erythroid precursors.
  • Refer to rheumatology and hematology. Severe cytopenias are urgent.
  • Treatment is specialist-led: glucocorticoids, IL-6 or JAK inhibitors (such as ruxolitinib), azacitidine in some, and stem cell transplant in selected patients. The 2025 ACR guidance advises against B-cell depletion and recommends considering clot prevention when hospitalized and PJP and zoster prophylaxis.

About this urgency level

Specialist evaluation helps, but these are usually less time-sensitive than new inflammatory arthritis or connective tissue disease.

Timeframes are typical targets. Local pathways, capacity and clinical judgment come first.